We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: UK stocks retreat from 14-year high, BoE in focus

Wed, 14th May 2014 08:43

- FTSE 100 pulls back after nearing record- BoE in focus ahead of inflation report- UK employment data due out- Compass unveils 1bn-pound cash returntechMARK 2,798.34 -0.21%FTSE 100 6,857.97 -0.22%FTSE 250 16,046.94 +0.05%UK stocks declined on Wednesday morning as investors took profits after markets closed at a 14-year high the previous session.The FTSE 100 was down 0.2% at 6,858 in early trading after hitting 6,873.08 on Tuesday, its best finish since reaching a record closing high of 6,930 at the end of December 1999."Whilst the markets have demonstrated a remarkable ability to shrug off the crisis in the Ukraine and interpret weak China data as a positive, there is a sense of foreboding about this upward move," said Jonathan Sudaria, a dealer at Capital Spreads.The Bank of England (BoE) is due to release new inflation and growth forecasts later today as the central bank comes under pressure to raise interest rates amid soaring house prices. The BoE has vowed to keep interest rates at a record low of 0.5% for an extended period but fears of a housing bubble have raised questions on whether the bank will move sooner to lift rates.Ahead of the interest rate report at 10:30, data is expected to show the unemployment rate fell again to 6.8% in the three months to March from 6.9% in the preceding three months. Employers during the period are projected to have added 248,000 new jobs, compared to 239,000 the previous quarter. Compass jumps after special dividendCatering giant Compass rose strongly this morning as the company hiked its interim dividend after a solid first half and unveiled a £1bn capital return to investors. "Strong cash generation has underpinned our investment in the business and our commitment to reward shareholders," said Chief Executive Richard Cousins.Paper and packaging group Mondi was also higher after delivering a 13% increase in underlying operating profits in the first quarter despite a "mixed" trading environment and flat sales volumes.Mining stocks were trading slightly lower this morning as sentiment in the industry was dampened by the news that over 200 people have been killed after an electrical fault at a mine triggered an explosion in western Turkey. Randgold Resources was a notable faller this morning.UK car insurer Admiral declined after reporting a 7% drop in first-quarter revenue as premiums continued to fall.Television network ITV underwhelmed with in-line ad revenues in the first quarter. However, the second quarter looks to beat expectations thanks to a spike in World Cup-related ads. Healthcare services provider UDG Healthcare impressed as it raised its full-year profit guidance, helped by a decent first half and the recent acquisition of the KnowledgePoint360 business.A number of heavyweight stocks were trading lower this morning after going ex-dividend, including Aberdeen Asset Management, Sage, GlaxoSmithKline, Shell, Glencore Xstrata, Kingfisher and J Sainsbury.FTSE 100 - RisersCompass Group (CPG) 1,029.00p +4.95%Mondi (MNDI) 1,054.00p +2.23%Aggreko (AGK) 1,710.00p +1.73%Petrofac Ltd. (PFC) 1,235.00p +1.48%RSA Insurance Group (RSA) 486.60p +0.72%easyJet (EZJ) 1,670.00p +0.72%Experian (EXPN) 1,072.00p +0.66%United Utilities Group (UU.) 840.00p +0.66%Babcock International Group (BAB) 1,248.00p +0.65%Vodafone Group (VOD) 221.25p +0.64%FTSE 100 - FallersITV (ITV) 181.90p -4.76%Sainsbury (J) (SBRY) 325.80p -3.89%Glencore Xstrata (GLEN) 324.20p -1.95%Randgold Resources Ltd. (RRS) 4,508.00p -1.81%Aberdeen Asset Management (ADN) 428.00p -1.72%Kingfisher (KGF) 410.90p -1.58%GlaxoSmithKline (GSK) 1,617.00p -1.22%Royal Dutch Shell 'B' (RDSB) 2,556.50p -1.16%Admiral Group (ADM) 1,433.00p -1.04%Royal Dutch Shell 'A' (RDSA) 2,346.50p -0.99%FTSE 250 - Risers3i Group (III) 393.60p +4.04%Partnership Assurance Group (PA.) 128.00p +3.06%Wood Group (John) (WG.) 792.50p +2.99%Galliford Try (GFRD) 1,215.00p +2.71%Booker Group (BOK) 154.10p +2.46%UDG Healthcare Public Limited Company (UDG) 368.00p +2.22%Senior (SNR) 293.70p +1.98%JD Sports Fashion (JD.) 1,735.00p +1.88%Euromoney Institutional Investor (ERM) 1,143.00p +1.60%Kentz Corporation Ltd. (KENZ) 720.50p +1.55%FTSE 250 - FallersRenishaw (RSW) 1,760.00p -4.30%Carillion (CLLN) 355.00p -3.32%Barr (A.G.) (BAG) 603.50p -2.35%Fidessa Group (FDSA) 2,294.00p -2.17%Perform Group (PER) 260.00p -1.89%Supergroup (SGP) 1,089.00p -1.89%PayPoint (PAY) 1,130.00p -1.74%Pace (PIC) 378.90p -1.71%Rank Group (RNK) 161.80p -1.64%Inmarsat (ISAT) 719.00p -1.64%BC
More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.